• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Intema and Squeezecmm Form Strategic Martech Partnership for Cross-platform Analytics and Advanced Email Deployment

Share:

December 2, 2019

Highlights on this story:
  • Marketing technology companies join forces to offer an enhanced, complementary service offering to a larger customer base
  • New potential market opportunity for Intema as SqueezeCMM’s major market and most of its customers are in the United States
  • Partnership to generate new revenue stream

Intema Solutions Inc. (“Intema” or the “Corporation”) (TSXV: ITM, OTCMKTS: ITMZF), makers of eFlyerMaker.com, an email platform with built-in compliance and content creation suites, and SqueezeCMM, an award-winning technology platform and professional services agency that tracks user behaviour and content marketing performance, announced a strategic partnership today that will include analytics integration and a single source for email, social and advertising performance, regardless of publishing platform.

“The combined offering is a win-win for both our companies, giving both access to the Canadian and US markets and offering our customers complementary technologies and service solutions,” said Laurent Benezra, President and CEO of Intema. “For the first time, marketers will be able to cost-effectively measure their digital marketing efforts through our combined service offering. We could not be more excited to offer advanced analytics via SqueezeCMM’s platform-agnostic data layer to the 18,000 customers currently using the eFlyerMaker email platform. We believe that this new partnership will attract customers seeking innovative, leading-edge marketing technology tools and could generate a new revenue stream in the coming quarters.”

The strategic partnership includes a combined sales approach in key vertical markets through the incorporation of the SqueezeCMM data layer into eFlyerMaker. “We love the eFlyerMaker platform and so do our customers − from beautiful templates and Photoshop-like editing capabilities to advanced list management and segmentation capabilities powered by a sophisticated machine-learning engine. It’s easy to use, yet also satisfies the requirements of even the most demanding customers,” said Jen Evans, CEO of SqueezeCMM. “We’re also excited about applying Intema’s advances in AI to our already vast dataset and retargeting capabilities.”

Customers who sign up for eFlyerMaker will now have access to SqueezeCMM’s multi-platform analytics engine. “SqueezeCMM’s taxonomy and retargeting capabilities make it one of the most configurable, cost-effective martech analytics solutions on the market,” said Kat Dodds, CEO of Hello Cool World and winner of the 2019 BC Achievement Community Award. “eFlyerMaker is the first email platform I’ve used that checks all the boxes, from compliance to design and list management. We’re excited to see how having all our digital marketing data in one place affects our budget decisions, and where this partnership can take our marketing!”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Business Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • H1 Acquires Carevoyance to Sell Its ’LinkedIn for Healthcare’ Platform to Medical Device CustomersH1 Acquires Carevoyance to Sell Its ’LinkedIn for Healthcare’ Platform to Medical Device Customers
  • Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-oncology NK Platform in Phase 1 Clinical Trials from Deverra TherapeuticsCoeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics
  • Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring ModelBiofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model
  • Sumitovant Biopharma and Urovant Sciences Announce Sumitovant’s Acquisition of Remaining Stake in UrovantSumitovant Biopharma and Urovant Sciences Announce Sumitovant’s Acquisition of Remaining Stake in Urovant
  • Takeda could rack up $10B in selloffs after controversial Shire buyoutTakeda could rack up $10B in selloffs after controversial Shire buyout
  • EL Camino Health Offers Personalized Chatbot to Patients with COPDEL Camino Health Offers Personalized Chatbot to Patients with COPD
  • Merck to Acquire OncoImmuneMerck to Acquire OncoImmune
  • Parexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Modeling Firm Model AnswersParexel Announces Acquisition of Leading Pharmacology Modeling & Analytics Modeling Firm Model Answers

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications